NEW YORK, Jan. 4, 2017 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Agile Therapeutics, Inc. ("Agile" or the "Company") (NASDAQ: AGRX). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980...
↧
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agile Therapeutics, Inc. - AGRX
↧